Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. 097900BGGW0000048796-20251231-EN-CON.zipPublication of the Annual Audited Consolidated Financial Statements of “Sopharma” AD for 2025

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 128 / 2026
Date of issue: 2026-04-29
Short name of the issuer
SOPHARMA AD
Subject
Publication of the Annual Audited Consolidated Financial Statements of “Sopharma” AD for 2025
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, 29 April 2026 – According to the requirements of art. 100n of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) presents the Annual Audited Consolidated Financial Statements, which contains:

• XHTML format of the report in accordance with the requirements of Commission Delegated Regulation (EU) 2018/815 of 17 December 2018 supplementing Directive 2004/109/EC of the European Parliament and of the Council with regulatory technical standards on the definition of a common electronic format for reports. It contains:
- Annual consolidated financial statements
- Notes to the annual consolidated financial statements
- Annual consolidated management report
- Corporate Governance Declaration
- Declaration by the responsible persons
- Audit report

• Annual reports according to a template determined by the Deputy Chairman of the Financial Supervision Commision;
• Electronic reference to the published inside information under Article 7 of Regulation (EU) №596 / 2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ L 173/1 of 12 June 2014) (Regulation (EU) № 596/2014) on the circumstances during the past year:
http://www.x3news.com/?page=News&uniqid=6242d3eba9dc7 https://www.sopharmagroup.com/bg/investitori/novini-za-investitori

Annexes
File Description
097900BGGW0000048796-20251231-EN-CON.zip
097900BGGW0000048796-20251231-EN-CON.zip		 Publication of the Annual Audited Consolidated Financial Statements of “Sopharma” AD for 2025

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-04-29 Ognian Ivanov Donev Executive Director
20260429_093206_1634117515_097900BGGW0000048796-20251231-EN-CON.zip

Pobierz